Methyl-2,3-dideoxy-3-fluoro-5-O-(4-phenylbenzoyl)-a-D-erythro-pentofuranoside
methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside
CAS: 168786-98-9
Molecular Formula: C19H19FO4
Methyl-2,3-dideoxy-3-fluoro-5-O-(4-phenylbenzoyl)-a-D-erythro-pentofuranoside - Names and Identifiers
| Name | methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside |
| Synonyms | METHYL-2,3-DIDEOXY-3-FLUORO-5-O-(4-phenylbenzoyl)-ALPHA-D-ERYTHRO- Methyl-2,3-dideoxy-3-fluoro-5-O-(4-phenylbenzoyl)-a-D-erythro-pentofuranoside Methyl-2,3-Dideoxy--Fluoro-5-O-(4-phenylbenzoyl)-Alpha-D-erythro-pentofuranoside methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside METHYL-2,3-DIDEOXY-3-FLUORO-5-O-(4-phenylbenzoyl)-ALPHA-D-ERYTHRO-PENTOFURANOSIDE Methyl 5-O-(4-biphenylylcarbonyl)-2,3-dideoxy-3-fluoro-α-D-erythr o-pentofuranoside α-D-erythro-Pentofuranoside, methyl 2,3-dideoxy-3-fluoro-, 5-[1,1'-biphenyl]-4-carboxylate Methyl 2,3-dideoxy-3-fluoro-alpha-D-erythro-pentofuranoside 5-[1,1'-biphenyl]-4-carboxylate |
| CAS | 168786-98-9 |
Methyl-2,3-dideoxy-3-fluoro-5-O-(4-phenylbenzoyl)-a-D-erythro-pentofuranoside - Physico-chemical Properties
| Molecular Formula | C19H19FO4 |
| Molar Mass | 330.35 |
Methyl-2,3-dideoxy-3-fluoro-5-O-(4-phenylbenzoyl)-a-D-erythro-pentofuranoside - Introduction
methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside is a compound with the chemical formula C21H19FO5 and its main properties are as follows:
1. Properties: methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside is a white solid or crystalline powder. It is almost insoluble in water at room temperature, but soluble in some organic solvents such as methanol and ether.
2. Use: methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside is a drug synthesis intermediate, commonly used in the synthesis of antiviral drugs and anticancer drugs.
3. Preparation method: The preparation of methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside is generally achieved by a chemical synthesis method. The specific preparation method requires organic synthesis reactions, such as the modification of the glycoside group and the introduction of fluorine atoms.
4. Safety Information: methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside need to pay attention to comply with the safety operation specifications of chemical laboratories during use. It may be irritating to the eyes, skin and respiratory system, so contact should be avoided. Wear appropriate personal protective equipment and maintain good ventilation during use. If external contact or inhalation is excessive, seek medical attention immediately. Detailed safety information and protective measures should refer to the relevant safety data sheet or enterprise-related information before use.
1. Properties: methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside is a white solid or crystalline powder. It is almost insoluble in water at room temperature, but soluble in some organic solvents such as methanol and ether.
2. Use: methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside is a drug synthesis intermediate, commonly used in the synthesis of antiviral drugs and anticancer drugs.
3. Preparation method: The preparation of methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside is generally achieved by a chemical synthesis method. The specific preparation method requires organic synthesis reactions, such as the modification of the glycoside group and the introduction of fluorine atoms.
4. Safety Information: methyl-2,3-dideoxy-3-fluoro-5-o-(4-phenylbenzoyl)-alpha-d-erythro-pentofuranoside need to pay attention to comply with the safety operation specifications of chemical laboratories during use. It may be irritating to the eyes, skin and respiratory system, so contact should be avoided. Wear appropriate personal protective equipment and maintain good ventilation during use. If external contact or inhalation is excessive, seek medical attention immediately. Detailed safety information and protective measures should refer to the relevant safety data sheet or enterprise-related information before use.
Last Update：2024-04-09 20:49:11
Supplier List
View History